MicroRNA and Cancer
| MicroRNA and Cancer |
| Autore | Tucci Paola |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (298 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
2'-O-methylation
adipokines B-CLL bioinformatics analysis biomarker blood biomarker brain tumour breast cancer Breast cancer cancer stem cell cancer stem cells ccRCC circulating biomarkers circulating microRNA colon cancer Cyclooxygenase-2 (COX-2) deformability diagnosis endometrial cancer estrogens exosome head and neck squamous cell carcinoma hepatocellular carcinoma hyperinsulinemia Hypoxia inducible factor 1-alpha (HIF-1α) immune checkpoint inhibitors immunotherapy insulin insulin resistance insulin signaling insulin-like growth factors malignant melanoma medulloblastoma meta-analysis metastasis metastatic melanoma methylation microRNA MicroRNA (miRNA) microRNAs Migration miR-584-5p miR526b miR655 miRNA miRNA-transcription factor network miRNAs n/a non-small cell lung cancer normal B-cell development ovarian cancer Oxidative stress PARP PI3K/Akt plasma prediction prognosis prognostic factor progression Prostaglandin E2 receptor 4 (EP4) pseudouridylation RCC regulation renal cancer replication stress serum LDH smoking snoRNA stem cells stemness subgroups survival targeted therapy therapy YKT6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580213503321 |
Tucci Paola
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Pathways in Cancers
| Molecular Pathways in Cancers |
| Autore | Cristóbal Ion |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (284 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
acetylation
actin cytoskeletal reorganization adaptive immunity advanced ovarian cancer anti-receptor therapy BET inhibitors biomarkers bladder cancer initiation breast cancer CALR cancer cancer immunology cancer therapeutics carcinogenicity CD99 agonist complement system DUSP1 EGFR dimerization endocytosis epigenetic epigenome epithelial cells FAK dephosphorylation genome glioblastoma gp120 hepatocellular carcinoma human immunodeficiency virus type 1 immune checkpoint inhibitors immune evasion immunotherapy innate immunity JAK2 luminal breast cancer MAPK matrix protein p17 metastasis metastatic melanoma methylation migration and invasion mitochondria molecular targeted agents MPL MS-determined phosphopeptides mTOR myeloproliferative neoplasms n/a Nef NIMA-related kinase 1 (NEK1) non-coding RNA OMD oncogenic signaling pathway ovarian cancer oxidative stress OXPHOS pancreatic ductal adenocarcinoma partial EMT patient survival pBRD4 PI3K PP2A PRELP prognosis prostate cancer PTPN12 Rac1 reactive oxygen species resistance reverse transcriptase RhoA SET signaling pathways small-cell lung cancer Snail splicing pathway TAK-228 Tat thioridazine (THD) tight junction tousled-like kinase (TLK) TPOR trastuzumab tripeptide triple negative breast cancer triple-negative breast cancer tumor immune microenvironment tumor microenvironment tumor suppression gene Warburg effect yes-associated protein 1 (YAP1) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566473703321 |
Cristóbal Ion
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||